Quick Answer
Bicara Therapeutics Inc. reported Shares Outstanding of 56.60 million shares for fiscal year 2025.
Bicara Therapeutics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 56.60M | +4.0% |
| 2024 | 54.44M | +8401.1% |
| 2023 | 640,386 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 54.61M | +0.4% | +0.1% |
| June 30, 2025 | 54.56M | — | +0.0% |
| March 31, 2025 | 54.53M | — | +0.2% |
| December 31, 2024 | 54.44M | +8401.1% | +0.1% |
| September 30, 2024 | 54.41M | — | +8396.4% |
| December 31, 2023 | 640,386 | — | — |
- Bicara Therapeutics Inc. showed an increase of +4.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, Bicara Therapeutics Inc.’s shares outstanding has grown by 8738.5% (from 640.4 thousand shares to 56.60 million shares).
- The most recent figure is from Bicara Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: